Bibliography

Research using CPRD data has informed drug safety guidance and clinical practice and resulted in over 2,300 peer-reviewed publications.

The CPRD bibliography is updated on a monthly basis (last updated 4 October 2019) and papers are listed below and in the PDF below.

If you have published papers using CPRD data which are not included in this list, please contact us at enquiries@cprd.com so that we can update the bibliography.

Download:

(PDF, 3MB, 190 pages)

 

Export 32 results:
Author Title [ Type(Desc)] Year
Filters: Author is Cardwell, C. R.  [Clear All Filters]
Journal Article
J. Busby, McMenamin, U., Spence, A., Johnston, B. T., Hughes, C., and Cardwell, C. R., Angiotensin receptor blocker use and gastro-oesophageal cancer survival: a population-based cohort study, Aliment Pharmacol Ther, vol. 47, pp. 279-288, 2018.
P. A. Vissers, Cardwell, C. R., van de Poll-Franse, L. V., Young, I. S., Pouwer, F., and Murray, L. J., The association between glucose-lowering drug use and mortality among breast cancer patients with type 2 diabetes, Breast Cancer Res Treat, vol. 150, pp. 427-37, 2015.
C. McCourt, Coleman, H. G., Murray, L. J., Cantwell, M. M., Dolan, O., Powe, D. G., and Cardwell, C. R., Beta-blocker usage after malignant melanoma diagnosis and survival: a population-based nested case-control study, Br J Dermatol, vol. 170, pp. 930-8, 2014.
C. R. Cardwell, Coleman, H. G., Murray, L. J., Entschladen, F., and Powe, D. G., Beta-blocker usage and breast cancer survival: a nested case-control study within a UK clinical practice research datalink cohort, Int J Epidemiol, vol. 42, pp. 1852-61, 2013.
B. M. Hicks, Murray, L. J., Powe, D. G., Hughes, C. M., and Cardwell, C. R., beta-Blocker usage and colorectal cancer mortality: a nested case-control study in the UK Clinical Practice Research Datalink cohort, Ann Oncol, vol. 24, pp. 3100-6, 2013.
B. M. Hicks, Murray, L. J., Hughes, C., and Cardwell, C. R., Clopidogrel use and cancer-specific mortality: a population-based cohort study of colorectal, breast and prostate cancer patients, Pharmacoepidemiol Drug Saf, vol. 24, pp. 830-40, 2015.
J. Busby, Murray, L., Mills, K., Zhang, S. D., Liberante, F., and Cardwell, C. R., A combined connectivity mapping and pharmacoepidemiology approach to identify existing medications with breast cancer causing or preventing properties, Pharmacoepidemiol Drug Saf, vol. 27, pp. 78-86, 2018.
O. B. Sanni, Menamin, U. C. Mc, Cardwell, C. R., Sharp, L., Murray, L. J., and Coleman, H. G., Commonly used medications and endometrial cancer survival: a population-based cohort study, Br J Cancer, vol. 117, pp. 432-438, 2017.
R. A. Karasneh, Murray, L. J., Menamin, U. C. Mc, Hughes, C. M., and Cardwell, C. R., Digoxin use after diagnosis of breast cancer and survival: a population-based cohort study, Breast Cancer Res Treat, vol. 151, pp. 661-9, 2015.
R. A. Karasneh, Murray, L. J., Hughes, C. M., and Cardwell, C. R., Digoxin use after diagnosis of colorectal cancer and survival: a population-based cohort study, Cancer Epidemiol Biomarkers Prev, vol. 24, pp. 1804-7, 2015.
R. A. Karasneh, Murray, L. J., Hughes, C. M., and Cardwell, C. R., Digoxin use after diagnosis of prostate cancer and survival: a population-based cohort study, Pharmacoepidemiol Drug Saf, vol. 25, pp. 1099-103, 2016.
C. R. Cardwell, Menamin, U. C. Mc, Hicks, B. M., Hughes, C., Cantwell, M. M., and Murray, L. J., Drugs affecting the renin-angiotensin system and survival from cancer: a population based study of breast, colorectal and prostate cancer patient cohorts, BMC Med, vol. 12, p. 28, 2014.
M. A. O'Rorke, Murray, L. J., Hughes, C. M., Cantwell, M. M., and Cardwell, C. R., The effect of warfarin therapy on breast, colorectal, lung, and prostate cancer survival: a population-based cohort study using the Clinical Practice Research Datalink, Cancer Causes Control, vol. 26, pp. 355-66, 2015.
C. R. Cardwell, Abnet, C. C., Veal, P., Hughes, C. M., Cantwell, M. M., and Murray, L. J., Exposure to oral bisphosphonates and risk of cancer, Int J Cancer, vol. 131, pp. E717-25, 2012.
C. R. Cardwell, Abnet, C. C., Cantwell, M. M., and Murray, L. J., Exposure to oral bisphosphonates and risk of esophageal cancer, Jama, vol. 304, pp. 657-63, 2010.
E. Morgan, Patterson, C. C., and Cardwell, C. R., General practice-recorded depression and antidepressant use in young people with newly diagnosed Type 1 diabetes: a cohort study using the Clinical Practice Research Datalink, Diabet Med, vol. 31, pp. 241-5, 2014.
C. R. Cardwell, McKinney, P. A., Patterson, C. C., and Murray, L. J., Infections in early life and childhood leukaemia risk: a UK case-control study of general practitioner records, Br J Cancer, vol. 99, pp. 1529-33, 2008.
U. C. Mc Menamin, Cardwell, C. R., Hughes, C. M., and Murray, L. M., Low-dose aspirin and survival from lung cancer: a population-based cohort study, BMC Cancer, vol. 15, p. 911, 2015.
C. R. Cardwell, Flahavan, E. M., Hughes, C. M., Coleman, H. G., O'Sullivan, J. M., Powe, D. G., and Murray, L. J., Low-dose aspirin and survival in men with prostate cancer: a study using the UK Clinical Practice Research Datalink, Cancer Causes Control, vol. 25, pp. 33-43, 2014.
C. R. Cardwell, Kunzmann, A. T., Cantwell, M. M., Hughes, C., Baron, J. A., Powe, D. G., and Murray, L. J., Low-dose aspirin use after diagnosis of colorectal cancer does not increase survival: a case-control analysis of a population-based cohort, Gastroenterology, vol. 146, pp. 700-708.e2, 2014.
U. C. Mc Menamin, Murray, L. J., Hughes, C. M., and Cardwell, C. R., Metformin use and survival after colorectal cancer: A population-based cohort study, Int J Cancer, vol. 138, pp. 369-79, 2016.
U. C. Menamin, Cardwell, C. R., Hughes, C. M., and Murray, L. M., Metformin use and survival from lung cancer: A population-based cohort study, Lung Cancer, vol. 94, pp. 35-9, 2016.
C. R. Cardwell, Carson, D. J., and Patterson, C. C., No association between routinely recorded infections in early life and subsequent risk of childhood-onset Type 1 diabetes: a matched case-control study using the UK General Practice Research Database, Diabet Med, vol. 25, pp. 261-7, 2008.
F. J. Bannon, O'Rorke, M. A., Murray, L. J., Hughes, C. M., Gavin, A. T., Fleming, S. J., and Cardwell, C. R., Non-steroidal anti-inflammatory drug use and brain tumour risk: a case-control study within the Clinical Practice Research Datalink, Cancer Causes Control, vol. 24, pp. 2027-34, 2013.
J. Busby, Mills, K., Zhang, S. D., Liberante, F. G., and Cardwell, C. R., Postdiagnostic Calcium Channel Blocker Use and Breast Cancer Mortality: A Population-based Cohort Study, Epidemiology, vol. 29, pp. 407-413, 2018.
B. M. Hicks, Murray, L. J., Hughes, C., and Cardwell, C. R., Post-diagnostic oral bisphosphonate use and colorectal cancer mortality: a population-based cohort study within the UK Clinical Practice Research Datalink, Br J Cancer, vol. 113, pp. 123-6, 2015.
L. J. Murray, Cooper, J. A., Hughes, C. M., Powe, D. G., and Cardwell, C. R., Post-diagnostic prescriptions for low-dose aspirin and breast cancer-specific survival: a nested case-control study in a breast cancer cohort from the UK Clinical Practice Research Datalink, Breast Cancer Res, vol. 16, p. R34, 2014.
J. Busby, Mills, K., Zhang, S. D., Liberante, F. G., and Cardwell, C. R., Selective serotonin reuptake inhibitor use and breast cancer survival: a population-based cohort study, Breast Cancer Res, vol. 20, p. 4, 2018.
C. R. Cardwell, Hicks, B. M., Hughes, C., and Murray, L. J., Statin use after colorectal cancer diagnosis and survival: a population-based cohort study, J Clin Oncol, vol. 32, pp. 3177-83, 2014.
C. R. Cardwell, Hicks, B. M., Hughes, C., and Murray, L. J., Statin use after diagnosis of breast cancer and survival: a population-based cohort study, Epidemiology, vol. 26, pp. 68-78, 2015.
C. R. Cardwell, U. Menamin, M., Hughes, C. M., and Murray, L. J., Statin use and survival from lung cancer: a population-based cohort study, Cancer Epidemiol Biomarkers Prev, vol. 24, pp. 833-41, 2015.
A. D. Spence, Busby, J., Hughes, C. M., Johnston, B. T., Coleman, H. G., and Cardwell, C. R., Statin use and survival in patients with gastric cancer in two independent population-based cohorts, Pharmacoepidemiol Drug Saf, 2018.
[Page last reviewed 4 October 2019]